Alnylam Pharmaceuticals (ALNY) shares rallied 8.5% in the last trading session to close at 243.27.Thismovecanbeattributabletonotablevolumewithahighernumberofsharesbeingtradedthaninatypicalsession.Thiscomparestothestock′s6243.27. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 6% loss over the past four weeks.The rise in share price came after President Trump announced a 90-day pause on his sweeping tariffs against non-retaliating countries.This RNA interference drug developer is expected to post quarterly loss of 243.27.Thismovecanbeattributabletonotablevolumewithahighernumberofsharesbeingtradedthaninatypicalsession.Thiscomparestothestock′s60.55 per share in its ...